179 related articles for article (PubMed ID: 34618539)
21. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.
Liu APY; Smith KS; Kumar R; Paul L; Bihannic L; Lin T; Maass KK; Pajtler KW; Chintagumpala M; Su JM; Bouffet E; Fisher MJ; Gururangan S; Cohn R; Hassall T; Hansford JR; Klimo P; Boop FA; Stewart CF; Harreld JH; Merchant TE; Tatevossian RG; Neale G; Lear M; Klco JM; Orr BA; Ellison DW; Gilbertson RJ; Onar-Thomas A; Gajjar A; Robinson GW; Northcott PA
Cancer Cell; 2021 Nov; 39(11):1519-1530.e4. PubMed ID: 34678152
[TBL] [Abstract][Full Text] [Related]
22. Intraoperative DNA methylation classification of brain tumors impacts neurosurgical strategy.
Djirackor L; Halldorsson S; Niehusmann P; Leske H; Capper D; Kuschel LP; Pahnke J; Due-Tønnessen BJ; Langmoen IA; Sandberg CJ; Euskirchen P; Vik-Mo EO
Neurooncol Adv; 2021; 3(1):vdab149. PubMed ID: 34729487
[TBL] [Abstract][Full Text] [Related]
23. The Epigenetic Landscape of Meningiomas.
Wang JZ; Nassiri F; Aldape K; von Deimling A; Sahm F
Adv Exp Med Biol; 2023; 1416():175-188. PubMed ID: 37432627
[TBL] [Abstract][Full Text] [Related]
24. Preoperative prediction of Ki-67 and p53 status in meningioma using a multiparametric MRI-based clinical-radiomic model.
Moon CM; Lee YY; Kim DY; Yoon W; Baek BH; Park JH; Heo SH; Shin SS; Kim SK
Front Oncol; 2023; 13():1138069. PubMed ID: 37287921
[TBL] [Abstract][Full Text] [Related]
25. Neurooncology: 2023 update.
Mittelbronn M
Free Neuropathol; 2023 Jan; 4():. PubMed ID: 37283935
[TBL] [Abstract][Full Text] [Related]
26. The Current Landscape of Immune Checkpoint Inhibitor Immunotherapy for Primary and Metastatic Brain Tumors.
Alimonti P; Gonzalez Castro LN
Antibodies (Basel); 2023 Apr; 12(2):. PubMed ID: 37092448
[TBL] [Abstract][Full Text] [Related]
27. Genomic markers of recurrence risk in atypical meningioma following gross total resection.
Vaubel RA; Kumar R; Weiskittel TM; Jenkins S; Dasari S; Uhm JH; Lachance DH; Brown PD; Van Gompel JJ; Jenkins RB; Kipp BR; Sukov WR; Giannini C; Johnson DR; Raghunathan A
Neurooncol Adv; 2023; 5(1):vdad004. PubMed ID: 36845294
[TBL] [Abstract][Full Text] [Related]
28. Brain Invasion and Trends in Molecular Research on Meningioma.
Go KO; Kim YZ
Brain Tumor Res Treat; 2023 Jan; 11(1):47-58. PubMed ID: 36762808
[TBL] [Abstract][Full Text] [Related]
29. Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome.
Guerrini-Rousseau L; Tauziède-Espariat A; Castel D; Rouleau E; Sievers P; Saffroy R; Beccaria K; Blauwblomme T; Hasty L; Bourdeaut F; Grill J; Varlet P; Debily MA
Acta Neuropathol Commun; 2023 Jan; 11(1):3. PubMed ID: 36609284
[No Abstract] [Full Text] [Related]
30. Peritumoral edema in meningiomas: pathophysiology, predictors, and principles for treatment.
Fiani B; Jarrah R; Bhandarkar AR; De Stefano F; Amare A; Aljameey UA; Reardon T
Clin Transl Oncol; 2023 Apr; 25(4):866-872. PubMed ID: 36427121
[TBL] [Abstract][Full Text] [Related]
31. Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features.
Choudhury A; Chen WC; Lucas CG; Bayley JC; Harmanci AS; Maas SLN; Santagata S; Klisch T; Perry A; Bi WL; Sahm F; Patel AJ; Magill ST; Raleigh DR
Neuro Oncol; 2023 Mar; 25(3):520-530. PubMed ID: 36227281
[TBL] [Abstract][Full Text] [Related]
32. Immune checkpoint inhibitor therapy for recurrent meningiomas: a retrospective chart review.
Nidamanuri P; Drappatz J
J Neurooncol; 2022 Apr; 157(2):271-276. PubMed ID: 35301639
[TBL] [Abstract][Full Text] [Related]
33. Preoperative Prediction of Intracranial Meningioma Grade Using Conventional CT and MRI.
Amano T; Nakamizo A; Murata H; Miyamatsu Y; Mugita F; Yamashita K; Noguchi T; Nagata S
Cureus; 2022 Jan; 14(1):e21610. PubMed ID: 35228967
[TBL] [Abstract][Full Text] [Related]
34. Co-activation of Sonic hedgehog and Wnt signaling in murine retinal precursor cells drives ocular lesions with features of intraocular medulloepithelioma.
Dottermusch M; Sumisławski P; Krevet J; Middelkamp M; Voß H; Siebels B; Bartsch H; Sotlar K; Meyer P; Frank S; Korshunov A; Glatzel M; Schüller U; Neumann JE
Oncogenesis; 2021 Nov; 10(11):78. PubMed ID: 34785636
[TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes.
Blobner J; Kilian M; Tan CL; Aslan K; Sanghvi K; Meyer J; Fischer M; Jähne K; Breckwoldt MO; Sahm F; von Deimling A; Bendszus M; Wick W; Platten M; Green E; Bunse L
Neurooncol Adv; 2021; 3(1):vdab147. PubMed ID: 34738084
[TBL] [Abstract][Full Text] [Related]
36. Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma Invasion.
Huang Y; Qi L; Kogiso M; Du Y; Braun FK; Zhang H; Huang LF; Xiao S; Teo WY; Lindsay H; Zhao S; Baxter P; Su JMF; Adesina A; Yang J; Brabetz S; Kool M; Pfister SM; Chintagumpala M; Perlaky L; Wang Z; Zhou Y; Man TK; Li XN
Adv Sci (Weinh); 2021 Dec; 8(23):e2101923. PubMed ID: 34719887
[TBL] [Abstract][Full Text] [Related]
37. Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study.
Jayachandran Preetha C; Meredig H; Brugnara G; Mahmutoglu MA; Foltyn M; Isensee F; Kessler T; Pflüger I; Schell M; Neuberger U; Petersen J; Wick A; Heiland S; Debus J; Platten M; Idbaih A; Brandes AA; Winkler F; van den Bent MJ; Nabors B; Stupp R; Maier-Hein KH; Gorlia T; Tonn JC; Weller M; Wick W; Bendszus M; Vollmuth P
Lancet Digit Health; 2021 Dec; 3(12):e784-e794. PubMed ID: 34688602
[TBL] [Abstract][Full Text] [Related]
38. Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies.
Adolph JE; Fleischhack G; Gaab C; Mikasch R; Mynarek M; Rutkowski S; Schüller U; Pfister SM; Pajtler KW; Milde T; Witt O; Bison B; Warmuth-Metz M; Kortmann RD; Dietzsch S; Pietsch T; Timmermann B; Tippelt S;
J Neurooncol; 2021 Nov; 155(2):193-202. PubMed ID: 34657224
[TBL] [Abstract][Full Text] [Related]
39. Spatially confined sub-tumor microenvironments in pancreatic cancer.
Grünwald BT; Devisme A; Andrieux G; Vyas F; Aliar K; McCloskey CW; Macklin A; Jang GH; Denroche R; Romero JM; Bavi P; Bronsert P; Notta F; O'Kane G; Wilson J; Knox J; Tamblyn L; Udaskin M; Radulovich N; Fischer SE; Boerries M; Gallinger S; Kislinger T; Khokha R
Cell; 2021 Oct; 184(22):5577-5592.e18. PubMed ID: 34644529
[TBL] [Abstract][Full Text] [Related]
40. Genomic Biomarkers of Meningioma: A Focused Review.
Pawloski JA; Fadel HA; Huang YW; Lee IY
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
